US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Pozen, Inc. (MM) (POZN)
Pozen, Inc. (MM) (POZN) ニュース

POZN

Pozen, Inc. (MM) (POZN)

Pozen, Inc. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:POZN

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2016/03/15	04 : 08	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:POZN	Pozen, Inc. (MM)
2016/03/15	02 : 23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:POZN	Pozen, Inc. (MM)
2016/03/15	02 : 21	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:POZN	Pozen, Inc. (MM)
2009/10/19	22 : 01	PR Newswire (US)	Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers	NASDAQ:POZN
2009/10/16	21 : 45	Dow Jones News	AstraZeneca Submits EU Marketing Application For Vimovo	NASDAQ:POZN	Pozen Inc.
2009/08/31	21 : 39	Dow Jones News	Pozen Earns $10 Million From AstraZeneca As FDA Accepts Drug Application	NASDAQ:POZN	Pozen Inc.
2009/06/30	21 : 57	Dow Jones News	AstraZeneca Partner Pozen Submits PN400 New Drug Application	NASDAQ:POZN	Pozen Inc.
2009/06/30	21 : 57	Dow Jones News	AstraZeneca Partner Pozen Submits PN400 New Drug Application	NASDAQ:POZN	Pozen Inc.
2007/06/09	02 : 00	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks	NASDAQ:POZN
2007/05/03	04 : 12	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks	NASDAQ:POZN
2007/05/03	04 : 09	PR Newswire (US)	Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms	NASDAQ:POZN
2006/05/04	06 : 21	PR Newswire (US)	American Stock Exchange to Trade Options on Six Securities	NASDAQ:POZN

Showing the most relevant articles for your search:NASDAQ:POZN

1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約